This week in PNAS Journal Club: A recent mouse study of long COVID finds fibroid-like lesions in the uterus, inflammation, and structural changes to the tissue, one year after infection from an analog of SARS-CoV-2.
“Raman Genome” for SARS-CoV-2: new Raman technology distinguishes viral variants by their molecular RNA architecture
Highly reliable LFIA based on selenium nanoparticle reveals long-term real-world dynamics of neutralizing antibodies against SARS-CoV-2 - EurekAlert!
New study shows antibodies need a strong core — not just grip — to fight SARS-CoV-2 - EurekAlert!
SARS-CoV-2 does not persist in the placenta after maternal recovery from COVID-19 - EurekAlert!
Global Virus Network monitors SARS-CoV-2 variant BA.3.2 (“Cicada”), emphasizes no cause for alarm - EurekAlert!
Most pandemic viruses don’t need "special" evolution to infect humans—they are already "pre-equipped" in the wild. While SARS-CoV-2 shows a purely natural signature, new genomic analysis confirms the 1977 H1N1 flu was likely a lab leak, providing a new framework to trace future outbreaks.
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
Why scientists are rethinking the immune effects of SARS-CoV-2
Study shows Sars-Cov-2 corrupts some white blood cells to suppress immune system, suggesting a path to severe Covid - EurekAlert!
AI learns to ‘speak’ genetic ‘dialect’ for future SARS-CoV-2 mutation prediction - EurekAlert
Robust mucosal SARS-CoV-2-specific T cells ef - EurekAlert
Computational drug discovery: Exploring natural products targeting SARS-CoV-2 - EurekAlert
Observing ozonated water’s effectiveness against SARS-CoV-2 in saliva - EurekAlert
Pre-pandemic artificial MERS analog of polyfunctional SARS-CoV-2 S1/S2 furin cleavage site domain is unique among spike proteins of genus Betacoronavirus | BMC Genomic Data
Evidence of human-to-animal SARS-CoV-2 transmission in a Brazilian zoo
SARS-CoV-2 'steals' our proteins to protect itself from the immune system
Assessing the efficacy of clinical drugs targeting SARS-CoV-2 main protease - EurekAlert
Peptide synthesized at University of São Paulo acts as molecular shield to prevent SARS-CoV-2 from infecting cells - EurekAlert
Antiviral-resistant variants of SARS-CoV-2 can emerge in immunocompromised people
